Stock Market

On the front-facing side of things, you might not find a better no-brainer (albeit highly speculative) narrative than Zomedica (NYSEAMERICAN:ZOM), the veterinary care specialist focusing on diagnostics platforms. Previously driven by intense meme pressure, ZOM stock found itself providing blistering returns before it all went sour. Source: Postmodern Studio / Shutterstock.com Unlike other meme trades
0 Comments
It’s been a little more than three weeks since Zomedica (NYSEAMERICAN:ZOM) reported its Q2 results. Despite reasonably healthy sales, ZOM stock gained just 14% from Aug. 11 through the end of the month.  Source: Postmodern Studio / Shutterstock.com Another InvestorPlace columnist, Ian Bezek, recently argued that Zomedica needs to raise its revenues considerably before investors
0 Comments
Support.com (NASDAQ:SPRT) holds its special meeting on Sept. 10 to vote on its merger with Greenridge Generation Holdings. The merger’s acceptance requires that more than 50% of owners of SPRT stock vote to approve the deal. Source: Shutterstock.com The two parties announced their merger on March 22. The day before the merger announcement, SPRT closed
0 Comments
Have you seen gene editing and sequencing stocks recently? Source: Connect world / Shutterstock.com Illumina (NASDAQ:ILMN) is up 20% over the past three months. Beam Therapeutics (NASDAQ:BEAM) is up 45%. Editas Medicine (NASDAQ:EDIT) is up 90%. Intellia Therapeutics (NASDAQ:NTLA) is up 150%. Folks, the Genomic Revolution is here. And while everyone can see those big
0 Comments
Although special purpose acquisition companies, or SPACs, gained notoriety over the trailing year-and-a-half period, they do offer a clear advantage to retail investors. Without these blank-check firms, regular folks may not have a chance to buy names like Skillz (NYSE:SKLZ) stock. Source: NYCStock / Shutterstock.com That’s because traditional market debuts are comparatively onerous, perhaps enough
0 Comments
Before Palantir Technologies (NASDAQ:PLTR) issued second quarter earnings early this month, I recommended the stock. Source: rblfmr / Shutterstock.com After analyzing the prospects for its data analysis software, I suggested that if you were looking for the next big thing, “this may be worth nibbling on.” Since then, shares are up 16% as the second
0 Comments
A company’s financials are everything – or are they? This could be a topic of debate surrounding SCWorx (NASDAQ:WORX) as the company isn’t in an ideal financial position, yet WORX stock has short-squeeze potential. Source: Shutterstock This begs a fundamental question, which all market participants should seriously consider: Should investors focus more on stocks or on
0 Comments
Robinhood (NASDAQ:HOOD) stock has significant growth potential over the longer term, but the immediate future is a little less rosy. Source: OpturaDesign / Shutterstock.com The valuation isn’t stratospheric and the company recently reported impressive second-quarter results. The problem is that HOOD stock faces risks, particularly in the medium term. As a result, I do not
0 Comments
Viasat (NASDAQ:VSAT) is satellite technology company that primarily provides bandwidth and internet services. These high-speed broadband services are targeted toward consumers, corporations and airlines. The company behind VSAT stock also provides connectivity systems to commercial networks. It’s third segment is government related in which VSAT produces secure government communication systems. Source: Shutterstock Viasat satellites are
0 Comments
Over the next 20 years, electric vehicles are going to take over the world. We all know this. Every investor, analyst, and financial media personality understands the enormous disruption coming to the multi-trillion-dollar mobility industry – and they all see it as the “investment opportunity of a lifetime.” Make no mistake. It is – but
0 Comments